Department of Pharmacology and Chemical Biology

2020-2021 Pharmacology and Chemical Biology Seminar Schedule

Master
Content

During the academic year, the department hosts seminars relevant to modern pharmacology, chemical biology, drug discovery and drug delivery. Unless otherwise noted, seminars are at 4 p.m. in room 201A. See the Zoom page.

Date Speaker Institution Topic
Sept. 1, 2020 Qingchun Tong UT McGovern Med School Why is it difficult to lose weight?
Sept. 8, 2020 Melanie Samuel Baylor College of Medicine Molecular regulators of neural wiring decisions
Sept. 15, 2020 Eric Van Nostrand Baylor College of Medicine A large-scale view of RNA biology
Sept. 22, 2020 Shao-Cong Sun UT MDA Cancer Center Molecular basis of antitumor T cell responses:
implications for cancer immunotherapy
Oct. 20, 2020 Ping Yi Baylor College of Medicine Structural Analysis of Nuclear Receptor-
coactivator complexes
Oct. 27, 2020 Lisa Bouchier-Hayes Baylor College of Medicine Adventures in Caspase Land: Investigating
Caspase Activation in Single Cells
Nov. 3, 2020 Wei Li Baylor College of Medicine Ligandomics and Drug Target Discovery
for Ocular Vascular Diseases
Nov. 10, 2020 Cheryl Lyn Walker Baylor College of Medicine The Secret Life of Chromatin Remodelers
Acting on the Cytoskeleton
Dec. 1, 2020 Ying Lu Harvard Medical School Exploring the conformational dynamics of
the 26S proteasome using its energy landscape
Jan. 5, 2021 Pingwei Li Texas A&M University The molecular basis of dsDNA sensing
through the cGAS-STING pathway 
Jan. 12, 2021 Yonghao Yu UT Southwestern
Medical Center 
Illuminating the Dark Matter within
Human Proteome: A Quantitative Mass Spectrometry Approach
Jan. 19, 2021 Amanda L. Garner University of Michigan Enabling Technologies for Revealing
Druggable Paths in RNA Biology
Jan. 26, 2021 David Rowley Baylor College of Medicine Carcinoma-Associated Fibroblasts and
Therapeutic Resistance in Cancer
Feb. 2, 2021 (starts at 9 a.m.) Georg Winter Center for Molecular
Medicine of the Austrian Academy of Sciences
Discovery and characterization of
novel molecular glue degraders
March 16, 2021 Anne Le Johns Hopkins University School of Medicine Metabolomics-Based Discovery of
Metabolic Aspects of Cancer and Other Diseases
April 13, 2021 (starts at 9 a.m.) Nir London Weizmann Institute of Science From covalent inhibitors to covalent PROTACs
April 20, 2021 John Buolamwini  Rosalind Franklin University
of Medicine and Science
Design and Discovery of Small Molecule
Drug/Probe Leads Against Targets in Heart Disease, Cancer and Drug Toxicity